Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blinded Clinical Trial to Evaluate the Incidence and Severity of Neuropsychiatric Side Effects and Antiviral Efficacy of Efavirenz Given as a Stepped Dosage Over 2 Weeks Versus the Usual Dosage in HIV-Infected Patients.

NCT00556634 is registered in ClinicalTrials.gov with Sociedad Andaluza de Enfermedades Infecciosas as lead sponsor.

NCT NCT00556634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00556634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blinded Clinical Trial to Evaluate the Incidence and Severity of Neuropsychiatric Side Effects and Antiviral Efficacy of Efavirenz Given as a Stepped Dosage Over 2 Weeks Versus the Usual Dosage in HIV-Infected Patients.
Lead sponsor
Sociedad Andaluza de Enfermedades Infecciosas
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
January 31, 2008
Enrollment
114 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, hiv-1 infection